251 related articles for article (PubMed ID: 21384463)
21. Detection of adverse drug reactions using hospital databases-a nationwide study in Portugal.
Miguel A; Bernardo Marques ; Freitas A; Lopes F; Azevedo L; Pereira AC
Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):907-13. PubMed ID: 23761351
[TBL] [Abstract][Full Text] [Related]
22. Annual cost of hospitalization, inpatient rehabilitation and sick leave of anal cancer in Germany.
Heitland W; Schädlich PK; Chen X; Rémy V; Moro L
J Med Econ; 2013; 16(3):364-71. PubMed ID: 23253056
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
Jha N; Bajracharya O; Namgyal T
Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
[TBL] [Abstract][Full Text] [Related]
24. Developing an adverse drug reaction reporting system at a teaching hospital.
Baniasadi S; Fahimi F; Shalviri G
Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):408-11. PubMed ID: 18312492
[TBL] [Abstract][Full Text] [Related]
25. Adverse drug reactions to antiretroviral therapy (ART): an experience of spontaneous reporting and intensive monitoring from ART centre in India.
Modayil RR; Harugeri A; Parthasarathi G; Ramesh M; Prasad R; Naik V; Giriyapura V
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):247-55. PubMed ID: 20066675
[TBL] [Abstract][Full Text] [Related]
26. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005.
Patel H; Bell D; Molokhia M; Srishanmuganathan J; Patel M; Car J; Majeed A
BMC Clin Pharmacol; 2007 Sep; 7():9. PubMed ID: 17894876
[TBL] [Abstract][Full Text] [Related]
27. [Detection and evaluation of adverse drug effects].
Thürmann PA; Schmitt K
Med Klin (Munich); 2000 May; 95(1 Spec No):4-8. PubMed ID: 10851841
[TBL] [Abstract][Full Text] [Related]
28. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
[TBL] [Abstract][Full Text] [Related]
29. Adverse drug reactions which provoke hospital admission.
Pérez Menéndez-Conde C; Bermejo Vicedo T; Delgado Silveira E; Carretero Accame E
Farm Hosp; 2011; 35(5):236-43. PubMed ID: 21570331
[TBL] [Abstract][Full Text] [Related]
30. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization.
von Euler M; Eliasson E; Ohlén G; Bergman U
Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):179-84. PubMed ID: 16184621
[TBL] [Abstract][Full Text] [Related]
31. Incidence and costs of adverse drug reactions in a tertiary care pediatric intensive care unit.
Du W; Tutag Lehr V; Caverly M; Kelm L; Reeves J; Lieh-Lai M
J Clin Pharmacol; 2013 May; 53(5):567-73. PubMed ID: 23553619
[TBL] [Abstract][Full Text] [Related]
32. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
Bénard-Laribière A; Miremont-Salamé G; Pérault-Pochat MC; Noize P; Haramburu F;
Fundam Clin Pharmacol; 2015 Feb; 29(1):106-11. PubMed ID: 24990220
[TBL] [Abstract][Full Text] [Related]
33. Reporting adverse drug reactions on a geriatric ward: a pilot project.
Somers A; Petrovic M; Robays H; Bogaert M
Eur J Clin Pharmacol; 2003 Feb; 58(10):707-14. PubMed ID: 12610749
[TBL] [Abstract][Full Text] [Related]
34. Direct medical costs of bronchiolitis hospitalizations in the United States.
Pelletier AJ; Mansbach JM; Camargo CA
Pediatrics; 2006 Dec; 118(6):2418-23. PubMed ID: 17142527
[TBL] [Abstract][Full Text] [Related]
35. Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission.
Goettler M; Schneeweiss S; Hasford J
Pharmacoepidemiol Drug Saf; 1997 Oct; 6 Suppl 3():S79-90. PubMed ID: 15073758
[TBL] [Abstract][Full Text] [Related]
36. [Bottom-up analysis of the case costs of stem cell transplantation and selected chemotherapies].
Stäbler W; Wagner B
Klin Padiatr; 2003; 215(3):179-84. PubMed ID: 12778360
[TBL] [Abstract][Full Text] [Related]
37. Adverse drug reaction-related hospitalisations: a population-based cohort study.
van der Hooft CS; Dieleman JP; Siemes C; Aarnoudse AJ; Verhamme KM; Stricker BH; Sturkenboom MC
Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):365-71. PubMed ID: 18302300
[TBL] [Abstract][Full Text] [Related]
38. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
39. [Adverse drug reactions and prescription errors: morbi-mortality].
Chaio S; Toibaro J; Valicenti P; Saidón P
Medicina (B Aires); 2013; 73(2):111-8. PubMed ID: 23570758
[TBL] [Abstract][Full Text] [Related]
40. [Undesirable effects of medicine in the Internal Medicine Service of the University Hospital Center du Point G].
Soukho-Kaya A; Minta DK; Diarra MT; Konaté A; Diallo B; Sidibé AT; Dembélé M; Bah M; Doumbia AA; Dao K; Tolo N; Camara BD; Sy D; Maiga MY; Traoré HA
Mali Med; 2010; 25(3):10-4. PubMed ID: 21441084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
